Introduction {#s1}
============

Salen ligands are a class of molecules that have been widely explored in the field of supramolecular chemistry. The most fascinating and promising use of salen derivatives is due to their chiral complexes with numerous metals. The salen structure, due to two contiguous stereogenic carbon atoms in the diimine bridge, creates a chiral pocket which can coordinate a metal cation (*via* imine nitrogen and phenolic oxygen atoms). Salen ligands rose to prominence thanks to the pioneering work of Jacobsen and Katsuki that paved the way to one of the most well-designed protocol for the enantioselective epoxidation of unfunctionalized alkenes catalyzed by chiral manganese salen complexes (Jacobsen, [@B18]; Katsuki, [@B22]; Yoon and Jacobsen, [@B36]; La Paglia Fragola et al., [@B23]; Trusso Sfrazzetto et al., [@B32]; Ballistreri et al., [@B5], [@B8]; Zammataro et al., [@B37]). Furthermore, salen ligands are structures of great value in homogeneous catalysis (Katsuki, [@B21]; Jacobsen, [@B19]; Cozzi, [@B11]; McGarrigle and Gilheany, [@B24]; Baleizao and Garcia, [@B4]; Wezenberg and Kleij, [@B34]; Whiteoak et al., [@B35]).

In recent years, our research group exploited these chiral salen-metal complexes as enantiomeric receptors for chiral guests. In fact, depending on the metal ion and different substituents in the aromatic ring of salen framework, these salen-metal complexes can be used as efficient enantioselective catalysts and highly sensitive chemosensors (D\'Urso et al., [@B14]; Puglisi et al., [@B27], [@B29], [@B28]). In particular, chiral uranyl salen complexes have proved to be excellent receptors for amino acid salts (Amato et al., [@B3], [@B2], [@B1]; Ballistreri et al., [@B7]; Pappalardo et al., [@B25]), since the uranyl metal center, acting as a Lewis acid, possesses an equatorial fifth position able to coordinate one molecule of carboxylate anion (Ballistreri et al., [@B6]; Brancatelli et al., [@B10]). These synthetic enantioselective receptors could help to better understand the mechanisms of drugs action; processes that are involved in immunological responses and processes of the storage of genetic information. Besides, slightly modification of their structures could lead to chemosensors, which due to their simple use, relatively low cost and high sensitivity are particularly significant in the chemical analysis.

Taking into account the salen ligand applications in the field of catalysis and enantiomeric recognition, previous studies have inspired us to extend current research on the synthesis of salen receptors comprising porphyrin macrocycles which, with their high stability and fluorescence properties, could greatly extend the use of salen ligands as chemosensors. Porphyrins, due to their rigid molecular structure, tunable substituents, large skeleton dimensions, and additional metallation sites in the core, are very attractive macrocycles for their applications in many technological fields (Beletskaya et al., [@B9]; Drain et al., [@B13]). In our strategy, the rational combination of porphyrin derivatives with chiral uranyl-salen ligands in one structure, would lead to chemosensors that possess unprecedented luminescence properties, that till now were precluded in uranyl-salen complexes due to the presence of uranyl metal center. Here we report on the synthesis of a novel uranyl salen-bis-porphyrin complex, in which two porphyrin subunits and the salen ligand are directly connected, and the enantiomeric recognition properties of this receptor toward selected α-aminoacids derivatives assessed by UV-vis and fluorescence measurements ([Figure 1](#F1){ref-type="fig"}).

![Uranyl salen-bis-porphyrin complex **1** and amino acid salts used as guests.](fchem-07-00836-g0001){#F1}

Materials and Methods {#s2}
=====================

General Experimental Methods
----------------------------

The NMR experiments were carried out at 27°C on a Varian UNITY Inova 500 MHz spectrometer (^1^H at 499.88 MHz, ^13^C NMR at 125.7 MHz) equipped with pulse field gradient module (Z axis) and a tuneable 5 mm Varian inverse detection probe (ID-PFG). ESI mass spectra were acquired on a API 2000-- ABSciex using CH~3~OH (positive ion mode). A JASCO V-560 UV-Vis spectrophotometer equipped with a 1 cm path-length cell was used for the UV-Vis measurements. Luminescence measurements were carried out using a Cary Eclipse Fluorescence spectrophotometer with resolution of 0.5 nm, at room temperature. The emission was recorded at 90° with respect to the exciting line beam using 10:10 slit-widths for all measurements. All chemicals were reagent grade and were used without further purification.

General Procedure for the Synthesis of TBA Amino Acid Derivates (Ballistreri et al., [@B7])
-------------------------------------------------------------------------------------------

An aqueous solution of tetrabutylammonium hydroxide (40% w/w, 13 mmol) was added to an aqueous suspension of the desired amino acid (13 mmol). The resultant reaction mixture was heated at 60°C for 2 h. Water was removed in vacuo at 80°C. The residue was dissolved in CH~2~Cl~2~ (10 mL), filtered and the solvent was evaporated in vacuo to afford in high yield the desired product.

Procedure for UV-vis and Fluorescence Titrations
------------------------------------------------

Two stock solutions of host and guest (1.0 × 10^−3^ M) in dry chloroform were prepared. From these, different solutions with different ratio receptor/guest (host concentration = 1.0 × 10^−6^ M) were prepared, and UV-vis and emission spectra were recorded at 25°C. Fluorescence titrations were carried out using λ~ex~ = 350 nm in dry chloroform, recording at λ~em~ = 650 and 715 nm. With this data treatment, the apparent binding affinities of receptor with amino acid guests were estimated using HypSpec (version 1.1.33) (Pappalardo et al., [@B26]), a software designed to extract equilibrium constants from potentiometric and/or spectrophotometric titration data. HypSpec starts with an assumed complex formation scheme and uses a least-squares approach to derive the spectra of the complexes and the stability constants. χ^2^-test (chi-square) was applied, where the residuals follow a normal distribution (for a distribution approximately normal, the χ^2^-test value is around 12 or less). In all of the cases, χ^2^ ≤ 10 were found, as obtained by 3 independent measurement sets.

Synthesis of Compound 4 (Johansson et al., [@B20])
--------------------------------------------------

5.0 g (0.0300 mol) of compound **2** (Dalla Cort et al., [@B12]) and 5.97 g of potassium phthalimide **3** (0.0322 mol) were placed in a 250 mL round-bottom flask. The reagents were dissolved in 100 mL of DMF. The reaction mixture was allowed to stir at room temperature for 48 h and then was heated at 55°C for 4 h. The reaction mixture was cooled down to room temperature and diluted with 250 mL of EtOAc and washed with water (3 × 200 mL). The organic layer was dried over anhydrous Na~2~SO~4~, filtered and evaporated. The product was purified by silica gel column chromatography (CHCl~3~) to afford 3.37 g (40 % yield) of compound **4**. ^1^H NMR (500 MHz, CDCl~3~): δ = 10.99 (s, 1H); 9.88 (s, 1H); 7.86-7.84 (m, 2H); 7.73-7.71 (m, 2H); 7.67 (s, 1H); 7.65-7.63 (dd, *J* = 8.5 Hz, *J* = 2.0 Hz, 1H); 6.95 (d, *J* = 8.5 Hz, 1H); 4.82 (s, 2H).

Synthesis of Compound 5
-----------------------

0.662 g (2.36 mmol) of compound **4** and 0.0171 g (0.036 mmol) of tetrabutylammonium tribromide were placed in a 20 mL round-bottom flask. In this flask 3.60 mL of 1,3-propanediol and 3.90 mL of triethyl orthoformate were added. The reaction mixture was allowed to stir at room temperature for 48 h, then diluted with 45 mL of EtOAc. The organic solution was washed with water (3 × 20 mL), dried over anhydrous Na~2~SO~4~, filtered and evaporated. The product was purified by silica gel column chromatography (cyclohexane/EtOAc 3:1) affording 0.732 g of white compound **5** (92% yield). ^1^H NMR (500 MHz, CDCl~3~): δ = 7.85 (s, 1H); 7.83--7.81 (m, 2H); 7.70--7.68 (m, 2H); 7.36--7.34 (dd, *J* = 8.5 Hz, *J* = 2.5 Hz, 1H); 7.28 (s, 1H); 6.84 (d, *J* = 8.5 Hz, 1H); 5.61 (s, 1H); 4.74 (s, 2H); 4.30--4.27 (m, 2H); 4.02--3.96 (m, 2H); 2.30-- 2.20 (m, 1H); 1.52-1.48 (m, 1H). ^13^C (125 MHz, CDCl~3~): δ = 25.6, 31.4, 40.9, 67.2, 102.9, 117.4, 122.1, 123.2, 127.6, 128.6, 131.3, 132.1, 133.9, 154.9, 168.0.

Synthesis of Compound 6
-----------------------

0.440 g (1.298 mmol) of compound **5** and 0.704 mL (0.713 mmol) of hydrazine monohydrate in 30 mL of EtOH were added in a round-bottomed flask of 50 mL. The reaction was heated at 90°C and monitored by TLC. After 20 min, the heating was interrupted. The reaction mixture was cooled down to room temperature and solvent was evaporated. The obtained white precipitate was diluted in 30 mL of water. The aqueous solution was extracted with CHCl~3~ (2 × 20 mL) which was previously passed through Al~2~O~3~ layer. The CHCl~3~ solution was dried over anhydrous Na~2~SO~4~, filtered and evaporated. Compound **6** (0.154 g, 57%) was obtained as a yellow oil. ^1^H NMR (500 MHz, CDCl~3~): δ = 7.18--7.16 (dd, *J* = 8.5 Hz, *J* = 2.0 Hz, 1H); 7.14 (s, 1H); 6.87--6.85 (d, *J* = 8.5 Hz, 1H); 5.65 (s, 1H); 4.33-4.30 (m, 2H); 4.04--3.99 (m, 2H); 3.77 (s, 2H); 2.32--2.30 (m, 1H); 1.54--1.50 (m, 1H). ^13^C NMR (125 MHz, CDCl~3~): 26.6; 45.7; 67.4; 102.4; 117.1; 122.2; 126.3; 129.2; 134.3; 154.0.

Synthesis of Compound 8
-----------------------

0.394 g (0.598 mmol) of compound **7** (Gaware et al., [@B17]) were dissolved in 20 mL of anhydrous DMF, in a round-bottomed flask. To this stirred solution 0.273 g (0.718 mmol) of HATU was added, and the resulting mixture was left to stir under N~2~ atmosphere at room temperature for 20 min. Then, solution of 0.130 g (0.623 mmol) of compound **6** in 5 mL of anhydrous DMF was poured into the reaction mixture, which was stirred under N~2~ atmosphere and room temperature, for other 40 min. Finally, 0.105 mL (0.623 mmol) of *N*\'*N*-diisopropylethylamine was added to the reaction mixture. The reaction was carried out in N~2~ atmosphere for 70 h. After this period, the reaction mixture was evaporated. The resulting precipitate was dissolved in 30 mL of CH~2~Cl~2~. The organic solution was washed with water (3 × 40 mL), dried over anhydrous Na~2~SO~4~ filtered and evaporated. Compound **8** was purified by silica gel column chromatography (CH~2~Cl~2~/MeOH 100:2) affording 80 mg (16% yield) of a purple solid. ^1^HNMR (500 MHz, CDCl~3~): δ = 8.85--8.61 (m, 8H); 8.29--8.26 (d, *J* = 8.0 Hz, 2H); 8.24--8.18 (m, 6H); 8.11--8.05 (d, *J* = 8.0 Hz, 2H); 7.90 (s, 1H); 7.78--7.72 (m, 9H); 7.37--7.33 (dd, *J* = 8.5 Hz, *J* = 2.0 Hz, 1H); 7.31 (d, *J* = 2.0 Hz, 1H); 6.96--6.93 (d, *J* = 8.5 Hz, 1H); 6.57 (s, 1H); 5.70 (s, 1H); 4.64 (d, 2H); 4.38--4.32 (m, 2H); 4.20--4.02 (m, 2H); 2.35--2.25 (m, 1H); 1.52-1.48 (m, 1H); −2.81 (s, 2H). ^13^C (125 MHz, CDCl~3~): δ = 25.7, 29.7, 43.9, 67.5, 102.9, 117.8, 118.5, 120.3, 125.3, 126.5 (x3), 126.7 (x3), 127.5 (x3) 127.7 (x3), 127.9, 129.2, 130.6, 131.7, 132.1, 134.4 (x2), 134.5, 134.6, 142.0, 142.7, 145.6, 150.3, 155.0.

Synthesis of Compound 9
-----------------------

0.080 g (0.094 mmmol) of compound **8** were dissolved in 1.74 mL of TFA, in a round-bottomed flask, and the resulting mixture was allowed to stir at room temperature for 3 h. Then, 10 mL of diethyl ether were added to the organic solution affording a green precipitate, that was filtered and crystallized using MeOH, to give 50 mg (67% yield) of a red solid. ^1^HNMR (500 MHz, CDCl~3~): δ = 11.04 (s, 1H); 9.96 (s, 1H); 8.96--8.86 (m, 8H); 8.33--8.29 (d, *J* = 8.0 Hz, 2H); 8.24--8.19 (m, 6H); 8.26--8.22 (d, *J* = 8.0 Hz, 2H); 7.80--7.72 (m, 9H); 7.70 (d, *J* = 2.0 Hz, 1H); 7.68--7.64 (dd, *J* = 8.5 Hz, *J* = 2.0 Hz, 1H); 7.05 (d, *J* = 8.5 Hz, 1H); 6.77 (t, 1H); 4.76 (d, 2H); −2.77 (s, 2H). ^13^C (125 MHz, CDCl~3~): δ = 43.0, 118.0, 118.1, 120.4, 121.2, 125.0, 125.2, 126.5, 126.7, 127.5, 127.8, 128.5, 129.0, 131.4, 132.1, 132.2, 132.6, 132.8, 132.9, 134.4, 134.5, 134.6, 136.6, 136.7, 142.0, 142.8, 149.5, 150.1, 150.3, 150.4, 167.2, 196.3. MS (ESI): *m*/*z* = 790.2 \[M + H\]^+^.

Synthesis of Salen-Bis-Porphyrin Ligand 10
------------------------------------------

In a round bottom flask, to a solution of 27.6 mg of salicylic-porphyrin **9** (0.0349 mmol) in absolute EtOH (10 mL) was added (1*R*,2*R*)-(+)-1,2-diphenylethylendiamine (3.7 mg, 0.0175 mmol). The reaction was stirred for 48 h at room temperature and monitored by TLC (CH~2~Cl~2~/CH~3~OH, 100:2). The reaction was quenched by evaporation of the solvent under reduced pressure, and salen-bis-porphyrin ligand **10** was purified by PLC (CH~2~Cl~2~/CH~3~OH, 100:2) to afford 24 mg of a red/purple solid compound (78% yield). ^1^HNMR (500 MHz, CDCl~3~): δ = 14.41 (bs, 2H); 8.86-8.74 (m, 16H); 8.30 (s, 2H); 8.25--8.07 (m, 20H); 7.77--7.66 (m, 20H); 7.29--7.15 (m, 12H); 6.97 (d, *J* = 8.5 Hz, 2H); 6.83 (t, 2H); 4.73 (s, 2H); 4.56 (d, 4H); −2.78 (s, 4H). ^13^C (125 MHz, CDCl~3~): δ = 43.3, 80.1, 117.2 (x2), 118.47, 118.53, 120.3 (x2), 120.5, 125.4 (x2), 126.3, 126.7 (x2), 127.7 (x3), 127.8 (x2), 128.4, 128.6, 131.0, 132.3, 133.5, 134.4 (x3), 134.5 (x2), 134.6, 139.0, 141.9, 142.0, 145.6, 160.4, 166.2, 167.4. MS (ESI): *m*/*z* = 1760.4 \[M + H\]^+^, *m*/*z* = 891.0 \[M + Na\]^2+^.

Synthesis of Uranyl Salen-Bis-Porphyrin Complex 1
-------------------------------------------------

To a solution of **10** (22 mg, 0.0125 mmol) dissolved in absolute ethanol (10 mL) was added uranyl acetate (5.3 mg, 0.0125 mmol). The reaction was stirred overnight at room temperature, and the resulting solid was filtered and dried to yield 27 mg of uranyl salen-bis-porphyrin complex **1** as a red powder (98% yield). ^1^HNMR (500 MHz, DMSO-*d*~6~): δ = 9.49 (s, 2H); 9.33 (s, 2H) 8.82--8.76 (m, 16H); 8.32--8.20 (m, 20H); 7.83--7.80 (m, 20H); 7.74--7.59 (m, 8H); 7.21 (t, 2H); 7.15 (m, 2H); 7.05 (d, 2H); 6.35 (s, 2H); 4.67--4.57 (m, 4H); −2.93 (s, 4H). ^13^C (125 MHz, DMSO-*d*~6~): δ = 42.2, 79.5, 119.0 (x2), 120.1, 120.2 (x2), 120.3, 122.7, 125.9 (x3), 126.6 (x2), 127.0 (x3), 127.2 (x2), 127.4 (x3), 127.5, 128.1, 128.2, 133.7, 133.9, 134.2 (x3), 135.2, 141.1, 141.6, 144.0, 166.0, 168.6, 171.2. MS (ESI): *m*/*z* = 1058 \[M+2EtOH+2H\]^2+^; *m*/*z* = 1077 \[M+2EtOH+Na+H\]^2+^.

Results and Discussion {#s3}
======================

Target uranyl salen-bis-porphyrin complex 1 was synthesized in seven steps starting from 5-Cl-methyl-salycilaldheyde 2 (Dalla Cort et al., [@B12]; Saffar-Telur, [@B31]) as shown in [Scheme 1](#S1){ref-type="fig"}. In the first step potassium phtalimide was treated with compound 2 to yield compound 4 (40%), which was then reacted with 1,3-propandiol to afford the acetal intermediate 5 (92%). Conversion of the phthalimido moiety into an amino group by treatment with hydrazine, under standard Gabriel conditions, yielded the compound 6 (57%). The condensation reaction between compound 6 and 5-(4-Carboxyphenyl)-10,15,20-triphenylporphyrin 7 (Gaware et al., [@B17]) which was activated using HATU (Gangemi et al., [@B16]), afforded the porphyrin derivative 8 (16%), which was then treated with TFA to remove the acetal moiety and yield the salicylic-porphyrin 9 (67%). Condensation of 9 with the (1*R*,2*R*)-(+)-1,2-diphenylethylendiamine yielded salen ligand 10 (78%), which was finally converted into the corresponding salen complex 1 (98 %) by uranyl acetate. The proposed structures for this new chiral uranyl--salen complex and all the intermediates compounds are consistent with the ^1^H and ^13^C NMR spectroscopy data as well as the ESI mass spectrometry data (see [Supplementary Material](#SM1){ref-type="supplementary-material"}).

![Synthesis of the uranyl salen-bis-porphyrin complex **1**.](fchem-07-00836-g0004){#S1}

The UV-vis spectrum of uranyl salen-bis-porphyrin complex **1** dissolved in CHCl~3~ solution shows an intense Soret band centered at 419 nm (ε = 6,26·10^5^ M^−1^ cm^−1^) and four Q-bands (515 nm; 550 nm; 590 nm; 646 nm) ([Figure 2](#F2){ref-type="fig"}). The UV-vis spectrum is similar to the 5-(4-Methoxycarbonylphenyl)-10,15,20-triphenylporphyrin (TPPCOOMe, the precursor of 5-(4-Carboxyphenyl)-10,15,20-triphenylporphyrin **7**) in the same solvent (Rong et al., [@B30]), suggesting that the insertion of the salen-UO~2~ does not change the spectroscopic behavior of the porphyrin. Furthermore, there is no evidence of aggregation even at higher concentration (2.5 μM), as confirmed by UV-Vis and fluorescence data. In addition, the luminescence measurements are in accordance with literature data for similar porphyrins, with two main emission bands centered at 650 and 715 nm (λ~ex~ 350 nm), respectively ([Figure 2](#F2){ref-type="fig"}).

![UV-Vis spectra **(Left)** and fluorescence spectra **(Right)** of uranyl salen-bis-porphyrin complex **1** in CHCl~3~ (1 μM).](fchem-07-00836-g0002){#F2}

After proving the luminescent properties of uranyl salen-bis-porphyrin complex **1**, enantioselective recognition properties were evaluated by UV-vis and fluorescence measurements in chloroform, in particular for fluorescence titrations, following the emission changes at these two emission wavelengths of porphyrin moiety (650 nm and 715 nm, by using λ~ex~ 350 nm). Unfortunately, the fluorescence titrations showed a small intensity variation with all the selected amino acid guests except for the *L*-tryptophan derivative, which led to a poor data fitting. For that reasons, binding constant values between uranyl salen-bis-porphyrin complex **1** and amino acid derivatives were determined by UV-vis titrations, following a decrease of the absorption at 419 nm upon addition of increasing aliquots of guests. A representative example of UV-vis titration and the fluorescence titration of uranyl salen-bis-porphyrin complex **1** with L-Trp-TBA are shown in [Figure 3](#F3){ref-type="fig"}.

![Representative UV-vis titration **(Left)** and fluorescence titration **(Right)** of uranyl salen-bis-porphyrin complex **1** with ***L*-Trp-TBA** (λ~ex~ = 350 nm in dry chloroform).](fchem-07-00836-g0003){#F3}

[Table 1](#T1){ref-type="table"} reports the pertinent binding constant values with selected amino acid derivatives, the detection limit observed (DL) and the corresponding enantiomeric excess. In all cases, binding constant values have been calculated using 1:1 stoichiometry, suggested by Job\'s plots (see [Supplementary Material](#SM1){ref-type="supplementary-material"}).

###### 

Binding constant values *K* (M^−1^) with selected amino acid derivatives, detection limit observed (DL), and enantiomeric excess calculated by UV-vis titrations in dry chloroform at 25°C.

  **Guest**     **DL[^b^](#TN2){ref-type="table-fn"}**   ***K* (M^**−1**^)[^a^](#TN1){ref-type="table-fn"}**   **e.e**.
  ------------- ---------------------------------------- ----------------------------------------------------- --------------------------
  *D*-Phe-TBA   2.5 ppb                                  (8.13 ± 0.08) × 10^4^                                 *K~*L*~*/*K~*D*~* = 8.51
  *L*-Phe-TBA   1.6 ppb                                  (6.92 ± 0.07) × 10^5^                                 
  *D*-Ala-TBA   1.7 ppb                                  (9.77 ± 0.59) × 10^6^                                 *K~*D*~*/*K~*L*~* = 1.70
  *L*-Ala-TBA   1.3 ppb                                  (5.75 ± 0.05) × 10^6^                                 
  *D*-Trp-TBA   1.6 ppb                                  (4.33 ± 0.09) × 10^6^                                 *K~*D*~*/*K~*L*~* = 4.04
  *L*-Trp-TBA   1.1 ppb                                  (1.07 ± 0.01) × 10^6^                                 

*Calculated by HypSpec v1.1.33*.

*Caculated by method of the calibration curve using the formula DL = 3σ/K, where σ is the standard deviation of the blank, and K is the slope of the calibration curve*.

Notably, due to the presence of the porphyrin moieties, receptor **1** is able to detect the amino acid guests at low concentration. In fact, 1 μM solution of uranyl salen-bis-porphyrin complex **1** is able to detect amino acid derivatives at very low concentrations (ppb).

Enantiomeric recognition is very efficient with the ***L*-Phe-TBA**, which is recognized more than 8 times respect to the *D*-enantiomer (*K*~*L*~/*K*~*D*~ = 8.51). A good enantioselectivity is also observed for the ***D*-** and ***L*-Trp-TBA** pair (*K*~*D*~/*K*~*L*~ = 4.04). Moreover, for the ***L*-Trp-TBA** we were able to determine the binding constant value by fluorescence titration (*K* (M^−1^ = 2.63 ± 0.03 × 10^6^), in good agreement with the value calculated by UV-vis titration. In particular, a decrease of the emission intensity has been observed, probably due to a photoinduced electron transfer mechanism (PET) (Trusso Sfrazzetto et al., [@B33]). Only the ***D*-** and ***L*-Ala-TBA** (*K*~*D*~/*K*~*L*~ = 1.70) pair shows a slight selective recognition. With the smaller amino acid guest, coordination to the uranyl metal center appears less susceptible to the different configurations of the carbon atom stereocenter and then the molecular recognition is less selective. With aromatic amino acid derivatives, the possibility for the carboxylate anion to bind the fifth equatorial coordination site of the uranyl metal and, at the same time, to exploit CH-π interactions with the salen moiety and the porphyrin macrocycles of receptor **1** might be responsible for the strong observed enantioselectivity. Moreover, the strong recognition for the ***L*-Phe-TBA** enantiomer is in contrast with respect to those observed with our previous receptors having the same configuration of the chiral diamine bridge (*R, R*) (Ballistreri et al., [@B7]; Amato et al., [@B1]; Pappalardo et al., [@B25]; Forte et al., [@B15]). Probably, the presence of the two porphyrin arms not only increase the limit of detection by the presence of a fluorescence signal, but also plays a fundamental role in the recognition event.

Conclusion {#s4}
==========

We have synthesized a new chiral uranyl salen complex bearing two porphyrin macrocycles and evaluated the enantiomeric recognition properties of this complex toward α-amino acid derivatives by UV-vis titrations. The presence of porphyrin arms lead to a receptor that possesses luminescence properties that are not quenched by the coordination with the uranyl cation, which decreases the fluorescence intensity in uranyl salen complexes. UV/Vis measurements and Job plots indicate the formation of 1:1 host--guest complexes. This receptor displays a very high selectivity toward amino acid derivatives, in particular for the two enantiomers of Phe-TBA. The two porphyrin macrocycles play a key role in the enantioselectivity interacting through CH--π with the aromatic moiety of aminoacids, leading to high binding affinities. Work is in progress in our laboratory to better understand the rules governing the interactions of this salen receptor with amino acid guests in order to design new host--guest systems that possess luminescence properties.
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